Company Filing History:
3 out of 3,923 
1 out of 8 Years Active: 2008-2017
Title: Inventor Sauveur-Michel Maira: Pioneering Innovations in Pharmaceutical Diagnostics
Introduction
Sauveur-Michel Maira, an accomplished inventor based in Habsheim, France, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of four patents, his work focuses on the development of innovative treatments targeting serious diseases, particularly cancer.
Latest Patents
Maira's latest patents showcase his dedication to enhancing cancer treatment methodologies. One of his notable inventions is a pharmaceutical diagnostic tool that relates to selective cancer treatment regimes. This invention is based on assaying for the presence or absence of glutamine or a nucleic acid that encodes glutamine at position 859 of the catalytic p110α subunit of PI3K. Furthermore, it includes methods for predicting patient responsiveness to (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide, alongside a kit for practical application.
Another significant patent involves Imidazoquinolines as dual lipid kinase and mTOR inhibitors. This invention details the use of specific compounds in treating diseases dependent on the mammalian target of rapamycin (mTOR) kinase. It encompasses methods for utilizing these compounds in warm-blooded animals, particularly humans, along with pharmaceutical preparations intended for effective disease treatment.
Career Highlights
Maira's professional journey includes valuable experiences at leading firms in the pharmaceutical industry. He has worked at Novartis AG and Novartis Forschungsstiftung, specifically at the Friedrich Miescher Institute for Biomedical Research. These positions have allowed him to contribute to groundbreaking research and development in the field of medicine.
Collaborations
Throughout his career, Maira has collaborated with esteemed colleagues like Christine Fritsch and Carlos Garcia-Echeverria. These partnerships have fostered an environment of shared expertise and innovation, enhancing the impact of their collective work in pharmaceutical advancements.
Conclusion
Sauveur-Michel Maira exemplifies the spirit of innovation within the pharmaceutical industry. His patents and professional journey highlight his commitment to improving cancer treatment and therapeutic interventions. As he continues to build on his foundation of inventions, Maira remains a significant figure in advancing medical science and technology.